# Role of Statin in Venous Dysfunction in Patients With Venous Thromboembolism Event

Study · id `cardio:ct-nct03988101` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03988101](<https://clinicaltrials.gov/study/NCT03988101>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03988101

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT03988101. Randomized; triple masking; primary purpose treatment. Start 2019-09-19 (actual); primary completion 2024-03-29 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT03988101, source copy `cardio:ctgov-nct03988101-2025-08-01`, retrieved 2026-10-31)
- Started: 2019-09-19 (actual) (ClinicalTrials.gov record NCT03988101, source copy `cardio:ctgov-nct03988101-2025-08-01`, retrieved 2026-10-31)
- Primary completion: 2024-03-29 (actual) (ClinicalTrials.gov record NCT03988101, source copy `cardio:ctgov-nct03988101-2025-08-01`, retrieved 2026-10-31)
- Completion: 2025-05-30 (actual) (ClinicalTrials.gov record NCT03988101, source copy `cardio:ctgov-nct03988101-2025-08-01`, retrieved 2026-10-31)
- Countries: South Korea (ClinicalTrials.gov record NCT03988101, source copy `cardio:ctgov-nct03988101-2025-08-01`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03988101-2025-08-01`, retrieved 2026-10-31)

## The registry's words

- Brief title: Role of Statin in Venous Dysfunction in Patients With Venous Thromboembolism Event
- Condition: Venous Thromboembolism
- Condition: Dyslipidemias
- Intervention (Drug): Rosuvastatin 20mg
- Intervention (Drug): Control
- Lead sponsor: Yonsei University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Rosuvastatin (`cardio:rosuvastatin`)
- Registry intervention is a member of this class by a sourced record link: Statins (`cardio:statins`)
- Registry lists this organization as the lead sponsor: Yonsei University (`cardio:org-yonsei-university`)

## Provenance

Content hash: 90bcac082609140e8da91047cfb3828bdb75247663263ac70a2c441cf103cecc
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
